Phillygenin Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis: Suppression of Inflammation and Wnt/β-Catenin Signaling Pathway

[1]  Cheng Wang,et al.  Phillygenin inhibited M1 macrophage polarization and reduced hepatic stellate cell activation by inhibiting macrophage exosomal miR-125b-5p. , 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[2]  H. Xin,et al.  Human amniotic mesenchymal stem cells-derived IGFBP-3, DKK-3, and DKK-1 attenuate liver fibrosis through inhibiting hepatic stellate cell activation by blocking Wnt/β-catenin signaling pathway in mice , 2022, Stem cell research & therapy.

[3]  Cheng Wang,et al.  Hepatoprotective effect of phillygenin on carbon tetrachloride-induced liver fibrosis and its effects on short chain fatty acid and bile acid metabolism. , 2022, Journal of ethnopharmacology.

[4]  Xiao-qiang Mo,et al.  Phillygenin Inhibits Helicobacter pylori by Preventing Biofilm Formation and Inducing ATP Leakage , 2022, Frontiers in Microbiology.

[5]  Kai Zhang,et al.  Phillygenin activates PKR/eIF2α pathway and induces stress granule to exert anti-avian infectious bronchitis virus. , 2022, International immunopharmacology.

[6]  Shao-wei Li,et al.  Animal and Organoid Models of Liver Fibrosis , 2021, Frontiers in Physiology.

[7]  D. Brenner,et al.  Molecular and cellular mechanisms of liver fibrosis and its regression , 2020, Nature Reviews Gastroenterology & Hepatology.

[8]  D. Fliser,et al.  WNT–β-catenin signalling — a versatile player in kidney injury and repair , 2020, Nature Reviews Nephrology.

[9]  Xianxing Jiang,et al.  The antimicrobial peptide YD attenuates inflammation via miR-155 targeting CASP12 during liver fibrosis , 2020, Acta pharmaceutica Sinica. B.

[10]  Naihua Hu,et al.  Phillygenin inhibits LPS-induced activation and inflammation of LX2 cells by TLR4/MyD88/NF-κB signaling pathway. , 2020, Journal of ethnopharmacology.

[11]  D. Brenner,et al.  Mechanisms of liver fibrosis and its role in liver cancer , 2020, Experimental biology and medicine.

[12]  Yimin Wang,et al.  Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt/β-catenin pathway , 2019, Stem Cell Research & Therapy.

[13]  M. Pinzani,et al.  Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues. , 2019, Molecular aspects of medicine.

[14]  Guimin Zhang,et al.  Phillygenin exhibits anti-inflammatory activity through modulating multiple cellular behaviors of mouse lymphocytes , 2019, Immunopharmacology and immunotoxicology.

[15]  Jun Li,et al.  Emerging role and therapeutic implication of Wnt signaling pathways in liver fibrosis. , 2018, Gene.

[16]  Y. Osawa,et al.  Wnt/β-Catenin Signaling as a Potential Target for the Treatment of Liver Cirrhosis Using Antifibrotic Drugs , 2018, International journal of molecular sciences.

[17]  W. Xing,et al.  Mechanism of combined use of vitamin D and puerarin in anti-hepatic fibrosis by regulating the Wnt/β-catenin signalling pathway , 2018, World journal of gastroenterology.

[18]  Longjiang Yu,et al.  Evaluation of the Pharmacokinetics and Hepatoprotective Effects of Phillygenin in Mouse , 2018, BioMed research international.

[19]  Xiao-ming Meng,et al.  Octreotide attenuates hepatic fibrosis and hepatic stellate cells proliferation and activation by inhibiting Wnt/&bgr;‐catenin signaling pathway, c‐Myc and cyclin D1 , 2018, International immunopharmacology.

[20]  Shuncai Zhang,et al.  The Flavonoid Quercetin Ameliorates Liver Inflammation and Fibrosis by Regulating Hepatic Macrophages Activation and Polarization in Mice , 2018, Front. Pharmacol..

[21]  S. Friedman,et al.  Hepatic stellate cells as key target in liver fibrosis. , 2017, Advanced drug delivery reviews.

[22]  Jun Zhou,et al.  Frizzled‐7 mediates TGF‐&bgr;‐induced pulmonary fibrosis by transmitting non‐canonical Wnt signaling , 2017, Experimental cell research.

[23]  Xiankui Li,et al.  Effects of exogenous thymosin β4 on carbon tetrachloride-induced liver injury and fibrosis , 2017, Scientific Reports.

[24]  R. Nusse,et al.  Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities , 2017, Cell.

[25]  M. Kohara,et al.  Selective inhibitor of Wnt/β-catenin/CBP signaling ameliorates hepatitis C virus-induced liver fibrosis in mouse model , 2017, Scientific Reports.

[26]  F. Tacke,et al.  Liver macrophages in tissue homeostasis and disease , 2017, Nature Reviews Immunology.

[27]  Y. Jung,et al.  Reversal of liver cirrhosis: current evidence and expectations , 2017, The Korean journal of internal medicine.

[28]  J. Iredale,et al.  Regression of Liver Fibrosis , 2017, Seminars in Liver Disease.

[29]  M. Maes,et al.  Experimental models of liver fibrosis , 2016, Archives of Toxicology.

[30]  F. Tacke,et al.  Mechanisms of liver fibrosis resolution. , 2015, Journal of hepatology.

[31]  D. Brenner,et al.  Recent advancement of molecular mechanisms of liver fibrosis , 2015, Journal of hepato-biliary-pancreatic sciences.

[32]  Hao Wang,et al.  HuangQi Decoction Improves Renal Tubulointerstitial Fibrosis in Mice by Inhibiting the Up-Regulation of Wnt/β-Catenin Signaling Pathway , 2015, Cellular Physiology and Biochemistry.

[33]  J. Trebicka,et al.  The carbon tetrachloride model in mice , 2015, Laboratory animals.

[34]  Chuanlong Zhu,et al.  Mest Attenuates CCl4-Induced Liver Fibrosis in Rats by Inhibiting the Wnt/β-Catenin Signaling Pathway , 2013, Gut and liver.

[35]  Y. Huang,et al.  Wnt signaling in liver fibrosis: progress, challenges and potential directions. , 2013, Biochimie.

[36]  Martina Schneider,et al.  Loss of Xenopus cadherin-11 leads to increased Wnt/β-catenin signaling and up-regulation of target genes c-myc and cyclin D1 in neural crest. , 2013, Developmental biology.

[37]  J. Iredale,et al.  Reversibility of liver fibrosis , 2012, Fibrogenesis & tissue repair.

[38]  K. Bae,et al.  Lignans from the Fruits of Forsythia suspensa (Thunb.) Vahl Protect High-Density Lipoprotein during Oxidative Stress , 2008, Bioscience, biotechnology, and biochemistry.

[39]  Christopher J. Parsons,et al.  Gene expression profile of quiescent and activated rat hepatic stellate cells implicates Wnt signaling pathway in activation. , 2006, Journal of hepatology.

[40]  J. Ladero,et al.  Liver fibrosis. , 2018, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

[41]  G. Gores,et al.  Hepatocellular carcinoma , 2016, Nature Reviews Disease Primers.

[42]  Y. Guo,et al.  Wnt/beta-catenin signaling: a promising new target for fibrosis diseases. , 2012, Physiological research.